Verana Health × COTA, Inc.
Verana Health, a real-world data (RWD) company, merged with and acquired COTA, Inc., a specialist in curating oncology RWD. [80, 92] The deal significantly expands Verana's data footprint, particularly in oncology, adding COTA's network of over 10 million cancer patients. [81] While the terms of the deal were not disclosed, it was supported by a $52 million equity investment in Verana from existing investors. [78, 80, 81] One source reported the acquisition price as $52M, but official press releases state this was financing to support the deal, with the actual price being undisclosed. [78, 80]
The asset
Merger with a real-world data company to acquire its high-fidelity, curated oncology datasets and analytics capabilities.
- 95M total patients in combined network
- 10M oncology patients in COTA network
The record
- Seller status
- Going concern
- Sector
- real-world data
- Modalities
- clinical_data, medical_records, real-world_data
- Jurisdiction
- US
- Personal data
- de-identified
What it means if you hold data
This transaction represents a major consolidation in the real-world evidence market, combining specialty data assets (ophthalmology, urology) with deep oncology data to create a more comprehensive RWD provider for life sciences companies.